Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$5.77 - $8.49 $189,388 - $278,667
-32,823 Reduced 51.77%
30,577 $211,000
Q3 2022

Nov 07, 2022

BUY
$3.75 - $7.39 $45,000 - $88,680
12,000 Added 23.35%
63,400 $401,000
Q2 2022

Aug 09, 2022

BUY
$2.94 - $5.23 $136,980 - $243,676
46,592 Added 969.05%
51,400 $212,000
Q1 2022

May 16, 2022

BUY
$4.07 - $10.6 $19,568 - $50,964
4,808 New
4,808 $23,000
Q3 2021

Nov 09, 2021

SELL
$11.24 - $21.0 $16,017 - $29,925
-1,425 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$18.04 - $22.09 $25,707 - $31,478
1,425 New
1,425 $45,000
Q4 2020

Feb 12, 2021

SELL
$27.5 - $37.92 $145,310 - $200,369
-5,284 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$34.44 - $43.75 $157,494 - $200,068
4,573 Added 643.18%
5,284 $285,000
Q2 2020

Aug 13, 2020

BUY
$27.12 - $45.97 $19,282 - $32,684
711 New
711 $43,000
Q1 2020

May 13, 2020

SELL
$26.16 - $63.5 $22,759 - $55,245
-870 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$46.96 - $61.67 $24,607 - $32,315
-524 Reduced 37.59%
870 $76,000
Q3 2019

Nov 12, 2019

BUY
$59.47 - $93.1 $71,007 - $111,161
1,194 Added 597.0%
1,394 $127,000
Q2 2019

Aug 13, 2019

BUY
$75.84 - $105.21 $15,168 - $21,042
200 New
200 $25,000
Q2 2018

Aug 13, 2018

SELL
$99.64 - $127.59 $45,635 - $58,436
-458 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$105.8 - $150.94 $110,032 - $156,977
-1,040 Reduced 69.43%
458 $78,000
Q4 2017

Feb 12, 2018

BUY
$81.25 - $130.7 $121,712 - $195,788
1,498
1,498 $266,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.